Analystreport

Madrigal Pharmaceuticals (NASDAQ:MDGL) was given a new $540.00 price target on by analysts at Piper Sandler. They now have an "overweight" rating on the stock.

Madrigal Pharmaceuticals, Inc.  (MDGL) 
Last madrigal pharmaceuticals, inc. earnings: 2/26 06:50 am Check Earnings Report
US:NASDAQ Investor Relations: madrigalpharma.com